Aim & Scope
The Journal of Clinical Investigation has a respected history as a vital publication for the physician and scientist alike. Since 1924, the JCI has published research that examines the basic science behind clinical presentation. The JCI continues to offer expanded commentary on published articles and series focused on critical topics in emerging areas of biomedicine. [1]
Continuations / Journal History
| ( 1924 - 9999 ) | Journal of Clinical Investigation (JCI) | ( 1958 - 1994 ) | Clinical Research |
Companion / Sister Periodical(s)
2379-3708 ( Online )
American Society for Clinical Investigation (ASCI)
2024
SY Ku , Y Wang , MM Garcia , ... , H Beltran
Journal of Clinical Investigation (JCI) , 2024
0
0
TWIST1+FAP+ fibroblasts in the pathogenesis of intestinal fibrosis in Crohn’s disease
Y Zhang , J Wang , H Sun , ... , B Su
Journal of Clinical Investigation (JCI) , 2024
0
0
PN Shah , GA Romar , A Manukyan , ... , SJ Divito
Journal of Clinical Investigation (JCI) , 2024
0
0
T Mathis , F Baudin , AS Mariet , ... , F Sennlaub
Journal of Clinical Investigation (JCI) , 2024
0
0
Bi-allelic variants in RINT1 present as early-onset pure hereditary spastic paraplegia
V Quiroz , L Planas-Serra , A Sveden , ... , D Ebrahimi-Fakhari
Journal of Clinical Investigation (JCI) , 2024
0
0
Randomised controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine
WS Lee , J Audsley , MC Trieu , ... , SJ Kent
Journal of Clinical Investigation (JCI) , 2024
0
0
ML Cohen , AN Brumwell , TC Ho , ... , C Jourdan Le Saux
Journal of Clinical Investigation (JCI) , 2024
0
0
M Riva , S Ferreira , K Hayashi , ... , A Pierani
Journal of Clinical Investigation (JCI) , 2024
0
0
Editorial Retractions, Expressions of Concern and External Notices
Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blisters
D Han , AY Lee , T Kim , ... , JH Kim
Journal of Clinical Investigation (JCI)2023 - VOLUME 133, ISSUE 23
1 37
J Li , AC Karaplis , DC Huang , ... , R Kremer
Journal of Clinical Investigation (JCI)2011 - VOLUME 121, ISSUE 12 pp 4655-4669.
77 68
CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders.
X Bai , D Miao , S Xiao , ... , AC Karaplis
Journal of Clinical Investigation (JCI)2016 - VOLUME 126, ISSUE 2 pp 667-680.
32 66
D Miao , B He , Y Jiang , ... , AC Karaplis
Journal of Clinical Investigation (JCI)2005 - VOLUME 115, ISSUE 9 pp 2402-2411.
125 47
Parathyroid hormone is essential for normal fetal bone formation.
D Miao , B He , AC Karaplis , D Goltzman
Journal of Clinical Investigation (JCI)2002 - VOLUME 109, ISSUE 9 pp 1173-1182.
93 39
EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis.
H Feng , GY Lopez , CK Kim , ... , SY Cheng
Journal of Clinical Investigation (JCI)2014 - VOLUME 124, ISSUE 9 pp 3741-3756.
60 47
Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth.
C Hoareau-Aveilla , T Valentin , C Daugrois , ... , F Meggetto
Journal of Clinical Investigation (JCI)2015 - VOLUME 125, ISSUE 9 pp 3505-3518.
25 81
Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway.
I Matushansky , E Hernando , ND Socci , ... , C Cordon-Cardo
Journal of Clinical Investigation (JCI)2007 - VOLUME 117, ISSUE 11 pp 3248-3257.
95 48